Cleared Traditional

K852791 - 7 FRENCH DUAL LUMEN COM CENT VEIN CATH SYS

K852791 is an FDA 510(k) clearance for 7 FRENCH DUAL LUMEN COM CENT VEIN CATH SYS, manufactured by Cardio-Vascular Innovations, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 127-day FDA review.

K852791 · Cardio-Vascular Innovations, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1985
Decision
127d
Days
Class 2
Risk

K852791 is an FDA 510(k) clearance for the 7 FRENCH DUAL LUMEN COM CENT VEIN CATH SYS. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Cardio-Vascular Innovations, Inc. (Chantilly, US). The FDA issued a Cleared decision on November 5, 1985 after a review of 127 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardio-Vascular Innovations, Inc. devices

FDA 510(k) Submission Details - K852791

510(k) Number K852791 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 1985
Decision Date November 05, 1985
Days to Decision 127 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 125d · This submission: 127d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 834
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K852791.
PHARMASEAL OVER-THE NEEDLE ARTERIAL CATHETER & STA
K853714 · American Pharmaseal Div. Ahsc · Jan 1986
ARROW BRACHIAL CENTRAL VENOUS CATH-KIT W/16GA & EC
K854137 · Arrow Intl., Inc. · Dec 1985
GUIDING CATHETER
K853998 · Target Therapeutics · Nov 1985
INFUSION CATHETER
K853997 · Target Therapeutics · Nov 1985
INFUSION CATHETER W/SIDE HOLES
K854000 · Target Therapeutics · Nov 1985
REPAIR KIT QUINTON TRIPLE LUMEN RIGHT ATRIAL CATHE
K853860 · Quinton, Inc. · Oct 1985